UBS AM’s Blend Labs BLND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.85K Sell
5,761
-341,887
-98% -$545K ﹤0.01% 3283
2026
Q1
$591K Buy
347,648
+44,836
+15% +$95.8K ﹤0.01% 2504
2025
Q4
$921K Buy
302,812
+5,820
+2% +$18.6K ﹤0.01% 2168
2025
Q3
$1.08M Sell
296,992
-292,972
-50% -$1.05M ﹤0.01% 1976
2025
Q2
$1.95M Buy
589,964
+264,764
+81% +$897K ﹤0.01% 2154
2025
Q1
$1.09M Sell
325,200
-49,482
-13% -$180K ﹤0.01% 2264
2024
Q4
$1.58M Buy
374,682
+194,310
+108% +$836K ﹤0.01% 2161
2024
Q3
$676K Buy
+180,372
New +$598K ﹤0.01% 2554

Other funds holding BLND

UBS AM's BLND Position: Q2 2026 in Review

UBS AM reduced its Blend Labs (BLND) stake by 98% in Q2 2026, selling an estimated $545K and leaving 5,761 shares worth $9.85K. The position accounts for ﹤0.01% of the portfolio, ranked #3283.

UBS AM first reported a position in BLND in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.95M in Q2 2025. 184 funds tracked by Wall St. Rank hold BLND as of Q2 2026.

  • UBS AM held 5,761 shares of Blend Labs worth $9.85K as of Q2 2026.
  • UBS AM sold 341,887 Blend Labs shares in Q2 2026, an estimated $545K.
  • Blend Labs made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3283 holding.
  • UBS AM first reported a position in Blend Labs in Q3 2024 and has held it in 8 quarters since.
  • UBS AM's Blend Labs position peaked at $1.95M in Q2 2025.
  • 184 funds tracked by Wall St. Rank held Blend Labs as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.